Ocrelizumab is a lupus disease drug which was developed by Roche Group, a Swiss pharmaceutical company, together with Biogen Idec with headquarters in Cambridge, Massachusetts.
Roche Group said Monday they has suspended a late-stage trial for a new lupus and rheumatoid arthritis drug after several patients died from infections. Read the rest of this entry »
A new study finds that psychotherapy can helps cut the incidence of psychological woes in patients with
The main cause of
Lupus treatments focus on how to
Every
ase that can affect to any part of the body, such as joints, skin, lungs, heart, kidney and brain, and other organs.